Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2473-2488

  Caldwell, Charles C ^a   Chen, Yi ^a   Goetzmann, Holly S ^a   Hao, Yonghua ^b   Borchers, Michael T ^a   Hassett, Daniel J ^a   Young, Lisa R ^a,c   Mavrodi, Dmitri ^d   Thomashow, Linda ^d   Lau, Gee W ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Cincinnati Children's Hospital   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROLINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MUCIN 5AC; PSEUDOMONAS EXOTOXIN; PYOCYANINE; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRONCHIECTASIS; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GOBLET CELL; IMMUNOHISTOCHEMISTRY; LUNG INJURY; LUNG LAVAGE; METAPLASIA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

EID: 73549097081     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090166     Document Type: Article

References (74)

1. Boucher RC: An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002, 54:1359-1371
2. Lyczak JB, Cannon CL, Pier GB: Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002, 15:194-222
3. Lau GW, Ran H, Hassett DJ, Kong FS: The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 2004, 10:599-606
4. Lau GW, Hassett DJ, Britigan BE: Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 2005, 13:389-397
5. Wilson RD, Sykes A, Watson D, Rutman A, Taylor GW, Cole PJ: Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 1988, 56:2515-2517
6. Shellito J, Nelson S, Sorensen RU: Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages. Infect Immun 1992, 60:3913-3915
7. Kamath J, Britigan BE, Cox C, Shasby M: Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells. Infect Immun 1995, 63:4921-4923
8. Muller M, Sorrell TC: Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun 1992, 60:2536-2540
9. Muller M, Sztelma K, Sorrell T: Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann NY Acad Sci 1994, 744:320-322
10. Muller M, Sorrell TC: Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun 1997, 65:2483-2487
11. Usher L, Lawson R, Geary I, Taylor C, Bingle C, Taylor G, Whyte M: Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002, 168:1861-1868
12. Allen L, Dockrell DH, Pattery T, Lee DG, Cornelis P, Hellewell PG, Whyte MK: Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol 2005, 174:3643-3649
13. Britigan B, Railsback M, Cox C: The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. Infect Immun 1999, 67:1207-1212
14. Denning G, Railsback M, Rasmussen G, Cox C, Britigan B: Pseudomonas pyocyanin alters calcium signaling in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 1998, 274:L893-L900
15. Denning G, Wollenweber L, Railsback M, Cox C, Stoll L, Britigan B: Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 1998, 66:5777-5784
16. Denning GM, Iyer SS, Reszka KJ, O'Malley Y, Rasmussen GT, Britigan BE: Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003, 285:L584-L592
17. Look DC, Stoll LL, Romig SA, Humlicek A, Britigan BE, Denning GM: Pyocyanin and its precursor phenazine-1-carboxylic acid increase IL-8 and intercellular adhesion molecule-1 expression in human airway epithelial cells by oxidant-dependent mechanisms. J Immunol 2005, 175:4017-4023
18. Nutman J, Berger M, Chase P, Dearborn D, Miller KM, Waller RL, Sorensen RU: Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine. J Immunol 1987, 138:3481-3487
19. Munro N, Barker A, Rutman A, Taylor G, Watson D, McDonald-Gibson WJ, Towart R, Taylor WA, Wilson R, Cole PJ: Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J Appl Physiol 1989, 67:316-323
20. Dormehl I, Ras G, Taylor G, Hugo N: Effect of Pseudomonas aeruginosa-derived pyocyanin and 1-hydroxyphenazine on pulmonary mucociliary clearance monitored scintigraphically in the baboon model. Nucl Med Biol 1991, 18:455-459
21. Forteza R, Lauredo I, Burch R, Abraham W: Extracellular metabolites of Pseudomonas aeruginosa produce bronchoconstriction by different mechanisms. Am J Respir Crit Care Med 1994, 149:687-693
22. Lauredo I, Sabater J, Ahmed A, Botvinnikova Y, Abraham W: Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. J Appl Physiol 1998, 85:2298-2304
23. Lau GW, Ran HM, Kong FS, Hassett DJ, Mavrodi D: Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004, 72:4275-4278
24. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280:295-298
25. Hu JY, Fan Y, Lin YH, Zhang HB, Ong SL, Dong N, Xu JL, Ng WJ, Zhang LH: Microbial diversity and prevalence of virulent pathogens in biofilms developed in a water reclamation system. Res Microbiol 2003, 154:623-629
26. Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ: Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol 2005, 187:4327-4337
27. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP: Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764
28. Holloway BW, Krishnapillai V, Morgan AF: Chromosomal genetics of Pseudomonas. Microbiol Rev 1979, 43:73-102
29. Ran H, Hassett DJ, Lau GW: Human Targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci USA 2003, 100:14315-14320
30. Ahmad-Nejad P, Häcker H, Rutz M, Bauer S, Vabulas RM, Wagner H: Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002, 32:1958-1968
31. Thakran S, Li H, Lavine CL, Miller MA, Bina JE, Bina XR, Re F: Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. J Biol Chem 2008, 283:3751-3760
32. King EO, Ward MK, Raney DE: Two simple media for the demonstration of pyocyanin and fluorescein. J Lab Clin Med 1954, 44:301-307
33. -/- mice. FASEB J 2002, 16:1313-1315
34. + T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 2002, 28:L1066-L1074
35. Thurlbeck WM: Measurement of pulmonary emphysema. Am Rev Respir Dis 1967, 95:752-764
36. Lyerla TA, Rusiniak ME, Borchers M, Jahreis G, Tan J, Ohtake P, Novak EK, Swank RT: Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. Am J Physiol Lung Cell Mol Physiol 2003, 285:L643-L653
37. Southam DS, Dolovich M, O'Byrne PM, Inman MD: Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 2002, 282:L833-L839
38. Eyles JE, Spiers ID, Williamson ED, Alpar HO: Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. J Pharm Pharmacol 2001, 53:601-607
39. Foster WM, Walters DM, Longphre M, Macri K, Miller LM: Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol 2001, 90:1111-1117
40. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002, 2:735-747
41. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 1999, 20:53-60
42. Rose MC, Piazza FM, Chen YA, Alimam MZ, Bautista MV, Letwin N, Rajput B: Model systems for investigating mucin gene expression in airway diseases. J Aerosol Med 2000, 13:245-261
43. Rose MC, Voynow JA: Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006, 86:245-278
44. Keane MP, Strieter RM, Belperio JM: Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol 2005, 25:429-463
45. Gharaee-Kermani M, Phan SH: Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des 2005, 11:3943-3971
46. Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ: Mechanisms of pulmonary fibrosis. Annu Rev Med 2004, 55:395-417
47. Jiang D, Liang J, Hodge J, Lu B, Zhu Z, Yu S, Fan J, Gao Y, Yin Z, Homer R, Gerard C, Noble PW: Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 2004, 114:291-299
48. Khan WI, Blennerhasset P, Ma C, Matthaei KI, Collins SM: Stat6 dependent goblet cell hyperplasia during intestinal nematode infection. Parasite Immunol 2001, 23:39-42
49. Darcan-Nicolaisen Y, Meinicke H, Fels G, Hegend O, Haberland A, Kühl A, Loddenkemper C, Witzenrath M, Kube S, Henke W, Hamelmann E: Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice. J Immunol 2009, 182:7501-7508
50. Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb M, Inman MD: Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study. Clin Exp Allergy 2009, 39:147-158
51. Blanchard C, Durual S, Estienne M, Bouzakri K, Heim MH, Blin N, Cuber JC: IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J Immunol 2004, 172:3775-3783
52. Finkelman FD, Yang M, Perkins C, Schleifer K, Sproles A, Santeliz J, Bernstein JA, Rothenberg ME, Morris SC, Wills-Karp M: Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. J Immunol 2005, 174:4630-4638
53. Longphre M, Li D, Gallup M, Drori E, Ordonez CL, Redman T, Wenzel S, Bice DE, Fahy JV, Basbaum C: Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999, 104:1375-1382
54. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, Nicolaides NC: Interleukin-9 up-regulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000, 22:649-656
55. Blease K, Schuh JM, Jakubzick C, Lukacs NW, Kunkel SL, Joshi BH, Puri RK, Kaplan MH, Hogaboam CM: Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 2002, 160:481-490
56. Song KS, Lee WJ, Chung KC, Koo JS, Yang EJ, Choi JY, Yoon JH: Interleukin-1β and tumor necrosis factor α induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem 2003, 278:23243-23250
57. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R: Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003, 278:17036-17043
58. Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VP, Warnock M, Grünig G: IL-13 and IFN-γ: interactions in lung inflammation. J Immunol 2001, 167:1769-77
59. Rankin JA, Picarella DE, Geba G, Temann U-A, Prasad B, DiCosmo B, Tarallo A, Stripp B, Whitsett J, Flavell RA: Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996, 93:7821-7825
60. Chapoval SP, Al-Garawi A, Lora JM, Strickland I, Ma B, Lee PJ, Homer RJ, Ghosh S, Coyle AJ, Elias JA: Inhibition of NF- κB activation reduces the tissue effects of transgenic IL-13. J Immunol 2007, 179:7030 -41
61. Evans CM, Kim K, Tuvim MJ, Dickey BF: Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 2009, 15:4-11
62. Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C: Activation of NF-κB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 1999, 95:5718-5723
63. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, Stahlman MT, Fulkerson PC, Rothenberg ME, Whitsett JA: Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004, 131:953-964
64. Glasser SW, Detmer EA, Ikegami M, Na C-L, Stahlman MT, Whitsett JA: Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 2003, 278:14291-14298
65. Takeyama K, Dabbagh K, Shim JJ, Dao-Pick T, Ueki IF, Nadel JA: Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 2000, 164:1546-1552
66. Gharaee-Kermani M, Ullenbruch M, Phan SH: Animal models of pulmonary fibrosis. Methods Mol Med 2005, 117:251-259
67. Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY: Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res 1988, 14:687-704
68. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J Exp Med 2001, 194:809-821
69. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Immunol Today 1998, 19:568-574
70. Belperio JA, D, M, Murray L, Burdick MD, Xue YY, Strieter RM, Keane MP: The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis. J Immunol 2004, 173:4692-4698
71. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD: Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells: implications for Pseudomonas-associated tissue injury J Clin Invest 1992, 90:2187-2196
72. Muller M: Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Radic Biol Med 2002, 33:1527-1533
73. Miyazaki H, Kuwano K, Yoshida K, Maeyama T, Yoshimi M, Fujita M, Hagimoto N, Yoshida R, Nakanishi Y: The perforin mediated apoptotic pathway in lung injury and fibrosis. J Clin Pathol 2004, 57:1292-1298
74. Mariencheck WI, Alcorn JF, Palmer SM, Wright JR: Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 2003, 28:528-537